These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 14990521)

  • 1. Cognitive-behavioural therapy in first-episode and early schizophrenia. 18-month follow-up of a randomised controlled trial.
    Tarrier N; Lewis S; Haddock G; Bentall R; Drake R; Kinderman P; Kingdon D; Siddle R; Everitt J; Leadley K; Benn A; Grazebrook K; Haley C; Akhtar S; Davies L; Palmer S; Dunn G
    Br J Psychiatry; 2004 Mar; 184():231-9. PubMed ID: 14990521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tayside-Fife clinical trial of cognitive-behavioural therapy for medication-resistant psychotic symptoms. Results to 3-month follow-up.
    Durham RC; Guthrie M; Morton RV; Reid DA; Treliving LR; Fowler D; Macdonald RR
    Br J Psychiatry; 2003 Apr; 182():303-11. PubMed ID: 12668405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised controlled trial of cognitive-behavioural therapy in early schizophrenia: acute-phase outcomes.
    Lewis S; Tarrier N; Haddock G; Bentall R; Kinderman P; Kingdon D; Siddle R; Drake R; Everitt J; Leadley K; Benn A; Grazebrook K; Haley C; Akhtar S; Davies L; Palmer S; Faragher B; Dunn G
    Br J Psychiatry Suppl; 2002 Sep; 43():s91-7. PubMed ID: 12271807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting relapse prevention and positive symptom in first-episode schizophrenia using brief cognitive behavioral therapy: A pilot randomized controlled study.
    Liu Y; Yang X; Gillespie A; Guo Z; Ma Y; Chen R; Li Z
    Psychiatry Res; 2019 Feb; 272():275-283. PubMed ID: 30594760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive behavioural therapy in clozapine-resistant schizophrenia (FOCUS): an assessor-blinded, randomised controlled trial.
    Morrison AP; Pyle M; Gumley A; Schwannauer M; Turkington D; MacLennan G; Norrie J; Hudson J; Bowe SE; French P; Byrne R; Syrett S; Dudley R; McLeod HJ; Griffiths H; Barnes TRE; Davies L; Kingdon D;
    Lancet Psychiatry; 2018 Aug; 5(8):633-643. PubMed ID: 30001930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dorsolateral prefrontal cortex activity predicts responsiveness to cognitive-behavioral therapy in schizophrenia.
    Kumari V; Peters ER; Fannon D; Antonova E; Premkumar P; Anilkumar AP; Williams SC; Kuipers E
    Biol Psychiatry; 2009 Sep; 66(6):594-602. PubMed ID: 19560121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive behavioral therapy for schizophrenia: an empirical review.
    Rector NA; Beck AT
    J Nerv Ment Dis; 2001 May; 189(5):278-87. PubMed ID: 11379970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of brief cognitive-behavioral therapy for schizophrenia delivered by mental health nurses: relapse and recovery at 24 months.
    Malik N; Kingdon D; Pelton J; Mehta R; Turkington D
    J Clin Psychiatry; 2009 Feb; 70(2):201-7. PubMed ID: 19210949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive-behavioural therapy and motivational intervention for schizophrenia and substance misuse. 18-month outcomes of a randomised controlled trial.
    Haddock G; Barrowclough C; Tarrier N; Moring J; O'Brien R; Schofield N; Quinn J; Palmer S; Davies L; Lowens I; McGovern J; Lewis S
    Br J Psychiatry; 2003 Nov; 183():418-26. PubMed ID: 14594917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Durability of the effects of cognitive-behavioural therapy in the treatment of chronic schizophrenia: 12-month follow-up.
    Tarrier N; Wittkowski A; Kinney C; McCarthy E; Morris J; Humphreys L
    Br J Psychiatry; 1999 Jun; 174():500-4. PubMed ID: 10616627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A program for relapse prevention in schizophrenia: a controlled study.
    Herz MI; Lamberti JS; Mintz J; Scott R; O'Dell SP; McCartan L; Nix G
    Arch Gen Psychiatry; 2000 Mar; 57(3):277-83. PubMed ID: 10711914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early intervention for relapse in schizophrenia: results of a 12-month randomized controlled trial of cognitive behavioural therapy.
    Gumley A; O'Grady M; McNay L; Reilly J; Power K; Norrie J
    Psychol Med; 2003 Apr; 33(3):419-31. PubMed ID: 12701663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychoeducational psychotherapy for schizophrenic patients and their key relatives or care-givers: results of a 2-year follow-up.
    Buchkremer G; Klingberg S; Holle R; Schulze Mönking H; Hornung WP
    Acta Psychiatr Scand; 1997 Dec; 96(6):483-91. PubMed ID: 9421346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A trial of compliance therapy in outpatients with schizophrenia or schizoaffective disorder.
    Byerly MJ; Fisher R; Carmody T; Rush AJ
    J Clin Psychiatry; 2005 Aug; 66(8):997-1001. PubMed ID: 16086614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brief cognitive-behavioural therapy for patients in the community with schizophrenia: randomised controlled trial in Beijing, China.
    Guo ZH; Li ZJ; Ma Y; Sun J; Guo JH; Li WX; Wang ZQ; Xu HL; Ng RM; Turkington D; Kingdon D
    Br J Psychiatry; 2017 Mar; 210(3):223-229. PubMed ID: 28069563
    [No Abstract]   [Full Text] [Related]  

  • 16. Predictors of outcome in brief cognitive behavior therapy for schizophrenia.
    Brabban A; Tai S; Turkington D
    Schizophr Bull; 2009 Sep; 35(5):859-64. PubMed ID: 19571248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms.
    McGorry PD; Yung AR; Phillips LJ; Yuen HP; Francey S; Cosgrave EM; Germano D; Bravin J; McDonald T; Blair A; Adlard S; Jackson H
    Arch Gen Psychiatry; 2002 Oct; 59(10):921-8. PubMed ID: 12365879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of age on outcome of psychological treatments in first-episode psychosis.
    Haddock G; Lewis S; Bentall R; Dunn G; Drake R; Tarrier N
    Br J Psychiatry; 2006 Mar; 188():250-4. PubMed ID: 16507967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive-behavioural therapy for refractory psychotic symptoms of schizophrenia resistant to atypical antipsychotic medication. Randomised controlled trial.
    Valmaggia LR; van der Gaag M; Tarrier N; Pijnenborg M; Slooff CJ
    Br J Psychiatry; 2005 Apr; 186():324-30. PubMed ID: 15802690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive-behavioural therapy for patients with schizophrenia: a multicentre randomized controlled trial in Beijing, China.
    Li ZJ; Guo ZH; Wang N; Xu ZY; Qu Y; Wang XQ; Sun J; Yan LQ; Ng RM; Turkington D; Kingdon D
    Psychol Med; 2015 Jul; 45(9):1893-905. PubMed ID: 25532460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.